The activated Ras oncogene can transform various mammalian cells and has been implicated in development of a high population of malignant human tumors. Recent studies suggest that generation of reactive oxygen species such as superoxide and H 2 O 2 is involved in cell transformation by the activated Ras. However, the nature of an oxidase participating in Ras-transformation is presently unknown. Here, we report that Ras oncogene up-regulates the expression of Nox1, a homologue of the catalytic subunit of the superoxide-generating NADPH oxidase, via the mitogenactivated protein kinase kinase-mitogen-activated protein kinase pathway, and that small interfering RNAs designed to target Nox1 mRNA effectively blocks the Ras transformed phenotypes including anchorageindependent growth, morphological changes, and production of tumors in athymic mice. Therefore, we propose that increased reactive oxygen species generation by Ras-induced Nox1 is required for oncogenic Ras transformation.
INTRODUCTION
Low levels of reactive oxygen species (ROS) have been implicated as an intracellular signaling molecule in multiple cellular processes such as proliferation, apoptosis, and senescence (1, 2) . As for growth factor responses, platelet-derived growth factor (3) and epidermal growth factor (4) generated ROS in vascular smooth muscle cells and fibroblast cells, respectively. Depletion of ROS by chemical antioxidants blocked induction of cell proliferation by these growth factors. Nerve growth factor-induced ROS production also appeared to be required for neuronal differentiation of PC12 cells (5) . The Nox family proteins Nox1-5, which are homologous to gp91phox, the catalytic subunit of phagocytic superoxide generating NADPH oxidase, have been identified recently in nonphagocytic cells, and each appears to exert a specific functional role in various tissues (6 -9) . Among them, Nox1 is unique in that it functions in mitogenic regulation: decreased expression of Nox1 inhibits cell growth of vascular smooth muscle cells (10) and dismutation of Nox1-generated superoxide to hydrogen peroxide mediated Nox1-induced cell growth and transformation (11) . However, it is not currently known whether Nox1 plays a mediating role in cell transformation by oncogenes, tumor suppressors, and other carcinogenic agents.
Activation of Ras triggers uncontrolled proliferation and morphological alteration, contributing to the malignant phenotype of transformed cells. Ras interacts with three major effector proteins (12) , Raf kinase, phosphatidylinositol 3Ј-kinase, and RalGDS proteins. Whereas these effector pathways exert essential roles in the signaling involved in Ras transformation, another downstream limiting factor has been suggested to account for the Ras transforming potential: elevations in intracellular superoxide mediate mitogenic signaling by RasVal12 (13) . This led us to investigate how Ras activates the ROS-generating machinery and whether Nox1 is responsible for the malignant transformation by Ras oncogene. In the experiments described below, we provide new evidence that Nox1 expression is activated by the Ras-mitogen-activated protein kinase kinase (MAPKK)-mitogen-activated protein kinase (MAPK) pathway, and small interfering (si) RNAs for Nox1 prevents the Ras oncogenetransformed phenotypes, suggesting the essential contribution of Nox1-generated ROS to the malignant transformation by Ras.
MATERIALS AND METHODS
The siRNA Constructions. DNA oligonucleotides encoding siRNA with loop sequence (TTCAAGAGA) were subcloned into the H1 promoter vector, pSilencer hygro (Ambion, Austin, TX) according to the manufacturer's instructions. On the basis of rat Nox1 cDNA sequences, siRNAs were designed as follows: 5Ј-TTATGAGAAGTCTGACAAG-3Ј for siNox1-N, 5Ј-GATTCT-TGGCTAAATCCCA-3Ј for siNox1-M, and 5Ј-GGACATTTGAACAA-CAGCA-3Ј for siNox1-C, respectively. All of the constructions were verified by sequencing. pSilencer hygro Negative Control plasmid (Ambion), encoding a hairpin siRNA of which the sequence is not found in the mouse, human, or rat genome databases, is used for a control vector.
Transfections. Rat and Human Nox1 cDNAs were subcloned into pEGFP-C1 vectors (Clontech, Palo Alto, CA) containing Green Fluorescent Protein (GFP-rNox1 and GFP-hNox1). siNox1-N, siNox1-M, siNox1-C, and control vector (4 g) were transfected into 1 ϫ 10 6 K-Ras-NRK cells by using Lipofectamine2000 (Invitrogen, Carlsbad, CA). Transfected cells were subjected to selection in DMEM supplemented with 10% fetal bovine serum and 400 g/ml hygromycin for 2 weeks. Surviving colonies were isolated. The presence of stably transfected vectors in the cells was confirmed by PCR with vector specific primers, M13F (GTTTTCCCAGTCACGAC) and 3.0Rev (GAGTTAGCTCACTCATTAGGC).
Cell Culture and Materials. NRK, K-Ras-NRK cells (Kirstein murine sarcoma virus-transformed NRK cells), and NIH3T3 cells were purchased from American Type Culture Collection (Manassas, VA). Cells were maintained in DMEM with 10% fetal bovine serum. siNox1-stably transfected cell lines were maintained with 100 g/ml hygromycin. One clone of siNox1-stably transfected K-Ras-NRK cells (K-Ras-NRK/siNox1-N-7) was transfected with pEGFP-C1 or GFP-hNox1 and subjected to selection with 600 g/ml G418 and 100 g/ml hygromycin for 2 weeks.
Real-Time PCR. Total RNA was harvested from cells with TRIzol (Invitrogen). Equal amounts of DNasel-treated total RNA (5 g) was reversetranscribed by Power Script (Clontech) with random primers (Random 9 mers; TAKARA, Kyoto, Japan), and the resulting first-strand cDNA was analyzed with ABI Prism 7700 sequence detection system and TaqMan reagents (PE Applied Biosystems, Foster City, CA) using the standard curve method according to the manufacturer's instructions. Equal amounts of templates were analyzed in duplicate. VIC-labeled Ribosomal 18S RNA (PE Applied Biosystems) was used for normalization. The TaqMan MGB probe and primer pairs were designed with ABI Primer Express software. The sequences of primer pairs for rat Nox1, those for mouse Nox1, and TaqMan MGB probe are as follows: forward (for rat), 5Ј-GGTCACTCCCTTTGCTTCCA-3Ј; reverse (for rat), 5Ј-GGCAAAGGCACCTGTCTCTCT-3Ј; forward (for mouse), 5Ј-TGT-GCAGACCACAACCTCAAA-3Ј; reverse (for mouse) 5Ј-GCCTAATTC-CTCCATCTCCTGTT-3Ј; and TaqMan MGB probe (for both rat and mouse), 5Ј-carboxyfluorescein-TCCAGTAGAAATAGATCTTT-carboxytetramethylrhodamine-MGB-3Ј.
Growth Curve. Cells (1 ϫ 10 4 ) were plated in 3.5-cm dishes and allowed to grow in DMEM with 10% fetal bovine serum. Cell numbers for each cell line were counted.
Soft Agar Assay. A 0.53% agar base layer containing growth nutrients was solidified in 6-cm dishes (14) . Cell suspensions in DMEM containing 0.3% agar and 10% fetal bovine serum were layered over the base layer to a final cell density of 1.5 ϫ 10 4 cells/dish. The appearance of colonies was monitored for up to 10 days.
Nitroblue Tetrazolium (NBT) Assay. NBT assay was performed by the methods described (6) . Briefly, 2 ϫ 10 5 cells were inoculated into 24-well plates in triplicate. 0.25% NBT in Hanks' solution was added to the serumstarved cells with or without 40 units of superoxide dismutase for 8 min at 37°C. Reduced NBT was quantified by determining the absorbance at 510 nm (extinction coefficient of 11,000 M Ϫ1 cm
Ϫ1
). Immunoblotting. Cells were lysed in radioimmunoprecipitation assay buffer (PBS, 0.1% SDS, 1% Na-deoxycholate, 1% Triton X-100, leupeptin 10 g/ml, pepstatin A 10 g/ml, and phenylmethylsulfonyl fluoride 1 mM). Lysates were incubated with Lammeli sample buffer containing DTT as a reducing agent for 2 h at 37°C. The same amount of proteins (20 g) was analyzed by SDS-gel electrophoresis, followed by immunoblotting.
Tumorigenicity Analysis. Athymic mice were used to determine the tumor formation by each transfected cell line. Trypsinized cells (1 ϫ 10 6 ) were suspended in 0.2 ml of PBS, and the cell suspensions were inoculated s.c. into the animal. All of the animals were observed for the formation of tumors for up to 1 month. Tumors at 14 days were measured with an external caliper, and volume was calculated.
In Vitro Phosphatidylinositol 3-Kinase (PI3K) Assay. Reactions were performed as described (15) . Briefly, Cell lysates were solubilized in lysis buffer {20 mM HEPES (pH 7.4), 150 mM KCl, 2 mM Na 3 VO 4 , 50 mM NaF, 5 mM EDTA, 20 mM 3-[(3-cholamidopropyl)dimethylammonio]-1 -propanesulfonic acid, 10 g/ml pepstatin A, and 1 mM phenylmethylsulfonyl fluoride} and subjected to immunoprecipitation with antibodies to p110 subunit of PI3K (UBI, New York, NY). The immunoprecipitates were incubated with 100 g phosphatidylinositol-3,4-bisphosphate and 5 M [␥-
32 P]ATP (3000 Ci/mmol) in the reaction buffer [20 mM HEPES (pH7.5), 10 mM MgCl 2 , and 0.5 mM EGTA] for 30 min at 37°C. The labeled phosphatidylinositol-3,4,5-triphosphate were extracted and separated by TLC, followed by autoradiography.
RESULTS

Activated Ras Stimulates Nox1 Expression through the MAPK Pathway.
To determine the functional role of Nox1 in Ras oncogene transformation, we first examined the expression level of Nox1 gene in Ras-transformed NRK cells stably expressing the K-RasVal12 oncogene (K-Ras-NRK). Real-time PCR analysis under optimized conditions showed that the level of Nox1 expression in K-Ras-NRK cells was markedly elevated, whereas little or no Nox1 expression was detected in untransformed NRK cells (Fig. 1A) . Furthermore, transient transfection of NRK cells with H-RasVal12 also increased the expression of Nox1 as compared with that in cells transfected with control vectors (Fig. 1B) , and similar results were obtained with NIH3T3 cells (Fig. 1E ), indicating that up-regulation of Nox1 gene expression was due to the activation of Ras. The expression of Nox1 was growth associated, as serum or epidermal growth factor, which promotes cell proliferation, induced a significant increase in the Nox1 expression within 12 h after the mitogen treatment ( Fig. 1, C and D) . This is consistent with previous observations that both platelet-derived growth factor and angiotensin II trigger superoxide formation and induce Nox1 expression in vascular smooth muscle cells (10) .
We next dissected the signaling pathway downstream of Ras that links Ras to the Nox1 gene expression. Augmented expression of Nox1 in K-Ras-NRK cells (Fig. 1A) was inhibited significantly by a MAPKK inhibitor, PD98059, and a similar inhibitory effect by the inhibitor was observed with mitogenic stimulation of the Nox1 induction by serum or epidermal growth factor (Fig. 1, C and D) . When the dominant active MAPKK mutant was overexpressed in NIH3T3 cells, (Fig. 1E) . Because the previous work proposed that Rac1 might be functionally required for Rasinduced superoxide generation, we addressed a question as to whether inhibition of Rac1 is able to block the Ras-induced up-regulation of Nox1 expression. Overexpression of the dominant-negative Rac1Asn17 had no significant effect on the Ras-dependent up-regulation of Nox1 mRNA expression (Fig. 1F) . This implies that at least Rac1 is not involved in Ras/MAPK-mediated transcriptional control of the Nox1 gene. Because the results implicated the critical role of activated MAPK in Ras-induced Nox1 expression, we examined whether oncogenic Ras has really activated MAPK in both transient and stable transfection. Lysates from transfectants were immunoblotted with antiphospho-MAPK antibodies. As shown in Fig. 1G , the MAPK activity was found to be markedly activated, which is in agreement with other studies (17) (18) (19) . In another control experiment, a PI3K inhibitor wortmannin (500 nM) did not block the elevated expression of Nox1 in H-Ras-NIH3T3 cells (data not shown). PD98059 actually inhibited the MAPKK activity in these cell systems as determined by immunoblotting with antiphospho-MAPK antibodies (Fig. 1G) . Furthermore, PD98059 had no inhibitory effect on the PI3K activity, indicating that the inhibitor did not interfere with the PI3K-mediated pathway (Fig. 1H) . These results suggest that oncogenic Ras and growth factor signalings induce the gene expression of Nox1 through the Ras-MAPKK-MAPK but not the PI3K-mediated pathway. By using reporter assay, we determined that the proximal 300 bp of the Nox1 promoter contains sufficient responsive elements for transcriptional activation by MAPK. 
Introduction of Rat Nox1-Specific siRNAs (siNox1-N, M, and C) in K-Ras-NRK Cells Suppresses the Malignant Phenotype.
Recent studies indicate that the introduction of siRNAs into mammalian cells can specifically silence cellular mRNAs without induction of the nonspecific IFN responses (20, 21) . Stable expression of siRNAs is able to direct persistent suppression of gene expression, allowing the analysis of loss-of-function phenotypes over long periods of time (22) . To investigate whether Nox1 mediates Ras oncogene transformation, we stably transfected rat Nox1-specific siRNAs (siNox1-N, M, and C) into K-Ras-NRK cells. Introduction of expression plasmids carrying siNox1 or a control vector into cells was verified by PCR with a set of vector-specific primers ( Fig. 2A) . Transfection of siNox1 significantly suppressed the anchorage-independent growth in soft agar as shown by the number of colonies formed (Fig. 2B) C-2, -3, and -7) , and for control vector-carrying cell lines, two clones were chosen (neg -1 and neg-3) . A, the presence of stably transfected vectors in the cell lines was confirmed by PCR with a set of vector-specific primers (M13F and 3.0Rev). B, anchorage-independent cell growth of indicated cell lines on soft agar. Triplicates are shown; bars, ϮSE. C, growth curves for indicated cell lines. Cells (10 4 ) were inoculated into dishes, and cell numbers were counted. The data are shown as triplicates; bars, ϮSE. D, comparison of morphological changes among cell lines indicated. Note that K-Ras-NRK/siNox1-N-7 became elongated, whereas control vector (neg-1) had no effect on morphology. Scale bar shows 30 m. E, green fluorescent protein (GFP)-rat Nox1 (GFP-rNox1) was cotransfected into Cos1 cells with siNox1s to evaluate the inhibitory effect of siNox1s on the expression of GFP-rNox1. The expression of GFPrNox1 was determined by immunoblotting with anti-GFP antibodies. The intensity of the bands was evaluated by densitmetry (arbitrary units). F, the effect of siNox1s on the expression of GFP-human Nox1 (GFP-hNox1) in which there are no target sequences of siNox1-N and siNox1-C. Note that indicated siNox1s had no effect on GFP-hNox1 expression. G, real-time PCR revealed that Nox1 mRNA expression was severely reduced in the cells carrying siNox1 constructs indicated, compared with control vector-transfected cells (neg-1). H, superoxide generation in indicated cell lines was determined in the presence or absence of superoxide dismutase by nitroblue tetrazolium reduction assay. The data are shown as triplicates; bars, ϮSE.
growth rate of siNox1-transfected K-Ras-NRK cells in liquid culture decreased, as well (Fig. 2C) . In contrast, control vectors had no growth-inhibitory effect. Of 18 clones isolated from siNox1 transfectants, 17 (94%) showed morphological alteration. Fig. 2D shows a typical morphological alteration in siNox1-N-7 clone similar to the cell shape seen in NRK cells. Control vectors had no effect on morphology. K-Ras-NRK cells carrying control vectors maintained a round morphology similar to that seen in parental K-Ras-NRK cells. We ensured that the level of Nox1 proteins was reduced by overexpression of siNox1 mRNA. Because anti-Nox1 antibodies are not currently available, GFP-tagged rat Nox1 and siNox1 were coexpressed. We detected two protein bands (82 and 79 kDa) of GFP-rat Nox1 on immunoblot (Fig. 2E) . The doublet structure was also reported by others (10) , and it may be due to the post-translational modification or the protein degradation. Coexpression of siNox1 decreased the production of GFP-rat Nox1 proteins (Fig. 2E) dependent on a dose of the Nox1 siRNA vectors, indicating that siNox1s efficiently eliminated GFP-Nox1 RNAs from cells (Fig. 2E) . In control experiments, expression of GFP-human Nox1 was not affected by siNox1, because human Nox1 sequences were not contained in siNox1 (Fig. 2F) . In fact, real-time PCR demonstrated that the level of endogenous Nox1 transcripts was markedly reduced in siNox1-transfected K-Ras-NRK cell clones (Fig. 2G) . We assessed the role of Nox1 in the activated Ras-induced generation of superoxide by using NBT reduction assay, which has been used to detect superoxide production by the NADPH oxidase (6). K-Ras-NRK cells elevated reduction of NBT, which was inhibited by superoxide dismutase treatment, as compared with NRK cells. In contrast, the transfection of siNox1 into K-Ras-NRK cells abolished this stimulatory effect of K-Ras oncogene on the ROS production (Fig. 2H) , indicating that Nox1 mediates elevated production of superoxide in Ras-transformed cells.
The Effects of siNox1 Are Rescued by a Construct That Cannot Be Knocked Out by siNox1 Constructs. In another set of control experiments, we tested whether the effects of siNox1 are rescued by a construct that cannot be knocked out by siNox1 constructs. For this purpose, K-Ras-NRK/siNox1-N-7 cells, in which the endogenous rat Nox1 had been silenced, were stably transfected with GFP-human Nox1. GFP-human Nox1 does not contain the rat Nox1 sequences chosen for siNox1 constructs, so that its expression is not suppressed by siNox1-N as mentioned above. Both a rounded morphology and increased growth rate, similar to those of K-Ras-NRK cells, were restored in siNox1-N-7 cells after transfection of GFP-human Nox1 (Fig. 3, A-D) . Similar rescue of transformation phenotypes was observed with other clones (data not shown). The results suggest that Nox1 contributes to oncogenic transformation by Ras, which is characterized by enhanced growth rate as well as by morphological alteration resulting from changes in organization of cytoskeletons and adhesive proteins. Because the DNA sequences chosen for rat Nox siRNA are absent in other Nox family members, it is unlikely that other Nox genes contributed to the transformation phenotypes.
A Nox1 Inhibitor Diphenylene Iodonium Affects Morphologies of Ras-Transformed Cells. The involvement of ROS in Ras-transformation phenotype can be concluded from the following observations. K-Ras-NRK cells transiently assumed a flat cell morphology close to that of NRK cells when K-Ras-NRK cells were treated with (Fig. 4) or antioxidant N-acetyl cysteine (10 mM; data not shown) overnight. This morphological reversion was also detectable in PD98059-treated KRas-NRK cells (Fig. 4) , which is consistent with the idea that upregulation of Nox1 by the Ras-MAPKK-MAPK pathway is crucial for Ras transformation.
The siNox1s Suppress Ras-Induced Tumor Formation. To test if the Ras-transformed cells can become less tumorigenic cells through overexpression of Nox1 siRNAs, control or siNox1 vectortransfected K-Ras-NRK cells were implanted into athymic mice. As shown in Fig. 5 , the control vector-transfected cells produced aggressive tumors within 2 weeks. By contrast, expression of siNox1 resulted in a marked decrease in tumor growth. Histologically, tumors formed by Nox1-overexpressing K-Ras-NRK cells exhibited an increased vascularity (data not shown), which is in agreement with the ability of Nox1 to trigger angiogenic switch, increasing vascular endothelial growth factor production (23) . The majority of cells in small tumors formed by siNox1 vector-transfected cells appeared to undergo necrosis (data not shown). Thus, Nox1 siRNAs inhibited development of tumors derived from Ras-transformed cells.
DISCUSSION
Although previous studies suggested the contribution of ROS production to Ras transformation (13) , it was obscure which oxidase has a clear mediating role in Ras oncogenic transformation. Here, we have shown that oncogenic Ras constitutively up-regulates expression of Nox1 through the MAPKK-MAPK pathway and that the ROS generating activity of Nox1 is required for cell transformation and tumorigenicity by Ras oncogene (see the schematic model in Fig. 6 ). Perhaps, increased intracellular ROS perturbs the important metabolic signalings, resulting in malignant transformation. Our study reveals a new molecular mechanism for the Ras transformation, in which a redox signaling molecule Nox1 functions as a critical mediator downstream of Ras. Irani et al. (13) reported previously that superoxidecontrolling mitogenic activity in Ras-transformed cells is mediated through a MAPK-independent pathway, based on their observation that MAPK was not activated in H-Ras-Val12 transformed NIH3T3 cells, whereas superoxide generation was elevated in the cells. Unlike the published results, however, we detected the constitutive activation of MAPK in Ras-transformed cells, which was also observed by many other studies (for example, [17] [18] [19] . The discrepancy is not clear at present, and it may depend on the experimental procedures or biological system used.
Our results indicate that silencing Nox1 expression by siRNA vectors resulted in both decreased growth rate and morphological reversion in K-Ras-NRK cells, suggesting that ROS generated by Nox1 targets at least two signaling pathways involved in cell growth control and reorganization of cytoskeletons. Regarding mitogenic control, tyrosine phosphorylation of MAPK and epidermal growth factor receptor was blocked by inhibition of the platelet-derived growth factor-induced increase in H 2 O 2 (3) and depletion of epidermal growth factor-induced H 2 O 2 (23), respectively. The inactivation of protein-tyrosine phosphatase by ROS seems to aid the maintenance of maximal tyrosine phosphorylation and growth factor-stimulated cell proliferation (4, 24) . Therefore, Nox1 might participate in regulation of cellular DNA synthesis in protein tyrosine phosphorylation/ dephosphorylation-dependent fashion. As for cytoskeleton reorganization, redox-dependent down-regulation of Rho by Rac has been shown recently to influence actin cytoskeleton rearrangement including lamellipodia formation and membrane ruffling (25) . Because these small G proteins are integrated into the Ras signaling pathway, this regulatory system could mediate the Nox1 effects on cell morphology and migration.
Our discovery gives rise to a possibility that Nox1 may play a mediating role in neoplastic growth of human cancer, in which activation mutations of K-Ras at codon 12 have been detected in 90% of pancreatic cancers and 50% of colon cancers (26) . In preliminary studies, we found that the Nox1 expression was up-regulated in some pancreatic cancer cells and that suppression of Nox1 blocked their transformation phenotypes. 4 Considering that ROS have been associated with tumor promotion and ROS production in malignant cells may involve induction of ROS-generating enzymes (27) , Nox1 could be a potential molecular target for therapeutic intervention of cancer development. 
